| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.3 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.089 | 0.3 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.3 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.3 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.3 |